ANGLE plc
$0.14
24H
Market Cap
Volume
Supply
Price Chart
About ANGLE plc - AGL.L
ANGLE plc is a publicly traded company that specializes in the development of cancer diagnostics, particularly focusing on products that can capture and analyze circulating tumor cells from blood samples. Their flagship product, the Parsortix system, allows for the capture and harvest of rare cells for analysis, which can aid in personalized cancer care and ongoing treatment decisions.
What are ANGLE plc's core values and mission statement?
ANGLE plc's mission is to improve cancer care and patient outcomes by delivering clinically actionable information from live circulating tumor cells (CTCs). The company values pioneering research and development, clinical rigor, and partnerships to advance diagnostics in oncology and fetal health.
Who founded ANGLE plc and when?
ANGLE plc was founded by Andrew Newland in 1994.
Who leads ANGLE plc?
As of the last update prior to the cutoff, ANGLE plc was led by founder and CEO Andrew Newland.
Where is ANGLE plc located, and what is its base country?
ANGLE plc is based in the United Kingdom.
On which exchanges is ANGLE plc traded?
ANGLE plc is listed and traded on the London Stock Exchange.
Historical data
ANGLE plc (AGL) Price Live Data
The live price of ANGLE plc (AGL) is $0.14, with a trading volume of 1,180,189 in the last 24 hours. Wrapstocks updates the AGL price in real-time. ANGLE plc is down -1.65% in the last 24 hours. The company has a live market cap of $363,852.24 and a supply of 2,605,810 AGL stocks.
ANGLE plc (AGL) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 11 hours and 21 minutes.
